The global Next-Generation Sequencing Data Analysis Market is expected to reach USD 4,556.9 million by 2030, registering a CAGR of 22.89% over the forecast period, according to a new report by Grand View Research, Inc. The growth can be attributed to a significant decline in the cost of NGS installation in clinical diagnosis. Furthermore, the accessibility of genomic and proteomic data is anticipated to create significant growth opportunities. In addition, a reduction in the cost of sequencing is anticipated to boost the adoption rate of NGS, which would further drive the industry. The availability of tools, such as the Targeted Methyl-Seq platform and Agilent’s HaloPlex capture system from EpiGentek Group Inc. has aided in the DNA methylation profiles determination in individual genomes. The COVID-19 pandemic has enhanced NGS usage and has created a huge demand.
The NGS tools can generate a significant amount of data for scientists to analyze and study pathogenesis. Researchers from industry, academia, and government have used data analysis technology to help in understanding the characteristics, phylogenetics, and processes of SARS-CoV2. NGS technologies have helped to unveil biological information that has not been studied yet using conventional technologies. For instance, NGS has helped study genomic patterns associated with various biological processes and epigenomics. However, issues related to accessing storage management, and analysis of data are anticipated to offer huge R&D prospects, thus, driving the industry growth. Researchers that use high-throughput sequencers demand software systems, such as Laboratory Information Management Systems (LIMS) to archive and handle sequencing information.
Furthermore, the introduction of workflow management system solutions, such as Galaxy and Chipster, drives demand for technological advancements in data storage and management. Demand for technologically advanced infrastructure to monitor the flow of data analysis process from data generation to preliminary analysis to higher-level analysis has increased. Moreover, NGS data analysis tools are being constantly upgraded for obtaining effective results and higher utility. For instance, in December 2021, Bionano Genomics launched BioDiscovery’s NxClinical Software Version 6.1 for genome analysis. The version enables enhanced visualization and interpretation of NGS data for cancer and genetic disease domains. Such developments are anticipated to drive the industry over the forecast period.
List of Key Players in Next-generation Sequencing Data Analysis Market
- Golden Helix, Inc.
- Bio-Rad Laboratories, Inc.
- SciGenom Labs Pvt. Ltd.
- DNAnexus Inc.
- Genuity Science
- Fabric Genomics, Inc.
- Congenica Ltd.
- QIAGEN
- DNASTAR, Inc.
- Pacific Biosciences of California, Inc.
- Eurofins Scientific
- Partek Incorporated
- Precigen Bioinformatics Germany GmbH
- PierianDx
- Agilent Technologies, Inc.
- F. Hoffmann-La Roche Ltd.
- Illumina, Inc.
- Verily Life Science
- Thermo Fisher Scientific, Inc.
Related Press Release@ Next-generation Sequencing Data Analysis Market Report
Next-generation Sequencing Data Analysis Market Report Highlights
- The services product segment dominated the industry in 2022. NGS has several advantages, in terms of speed and affordability, and many research institutes are unable to adopt it due to a lack of skilled professionals and sufficient computational infrastructure
- The tertiary analysis workflow segment captured the major revenue share in 2022 as it accounts for the complex and important step of NGS, which is linked with the interpretation of the results
- The in-house mode segment dominated the market in 2022 and is anticipated to remain dominant in the coming years. However, the outsourced mode segment is anticipated to witness the fastest growth rate from 2023 to 2030 owing to time and cost advantages
- The short-read sequencing segment held the maximum share in 2022 due to the high adoption of short-read sequencing techniques and their cost-effective nature & ability to work with DNA fragments and the availability of several tools & algorithms
- The academic research end-use segment dominated the market in 2022. A reduction in the NGS technology cost has fueled the NGS software platforms usage by several research centers & academic institutions for their research that require data interpretation
- North America captured the highest revenue share in 2022 owing to the presence of well-developed information technology companies, favorable reimbursement network, and high government funding and high public & private expenditures in the biotechnology sector
Next-generation Sequencing Data Analysis Market Report Scope
Report Attribute
Details
Market size value in 2023
USD 1,076.8 million
Revenue forecast in 2030
USD 4,556.9 million
Growth rate
CAGR of 22.89% from 2023 to 2030
Base year for estimation
2022
Historical data
2018 - 2021
Forecast period
2023 - 2030
Request For A Free Consultation@ https://www.grandviewresearch.com/request-free-consultation/3100/rfc
Next-generation Sequencing Data Analysis Market Segmentation
Grand View Research has segmented the global next-generation sequencing data analysis market based on product, workflow, mode, end-use, read length, and region:
Next-generation Sequencing Data Analysis Product Outlook (Revenue, USD Million, 2018 - 2030)
- Services
- NGS Commercial Software
- Platform OS/UI
- Analytical Software
- QC/Pre-processing Tools
- Alignment Tools & Software
- DNA Sequencing Alignment
- RNA Sequencing Alignment
- Protein Sequencing Alignment
- Others
Next-generation Sequencing Data Analysis Workflow Outlook (Revenue, USD Million, 2018 - 2030)
- Primary
- Secondary
- Read Mapping
- Variant Alignment & Variant Calling
- Tertiary
- Variant Annotation
- Application Specific
- Targeted Sequencing/Gene Panel
- Exome
- RNA Sequencing
- Whole Genome
- Chip Sequencing
- Others
Next-generation Sequencing Data Analysis Mode Outlook (Revenue, USD Million, 2018 - 2030)
- In-house
- Outsourced
Next-generation Sequencing Data Analysis Read Length Outlook (Revenue, USD Million, 2018 - 2030)
- Short Read Sequencing
- Long Read Sequencing
- Very Long Read Sequencing
Next-generation Sequencing Data Analysis End-use Outlook (Revenue, USD Million, 2018 - 2030)
- Academic Research
- Clinical Research
- Hospitals & Clinics
- Pharma & Biotech Entities
- Other Users
Next-generation Sequencing Data Analysis Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Thailand
- Latin America
- Brazil
- Mexico
- Argentina
- Middle East Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Kuwait
